Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-25
2011-01-25
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S127000, C544S283000, C546S200000
Reexamination Certificate
active
07875621
ABSTRACT:
The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions containing compounds of formula (I)wherein R1, R3, L, X, Y and Z have defined meanings.
REFERENCES:
patent: 4335127 (1982-06-01), Vandenberk et al.
patent: 5374637 (1994-12-01), Van Daele et al.
patent: 2004/0077667 (2004-04-01), Matsuoka et al.
patent: 2004/0176361 (2004-09-01), Fujio et al.
patent: 0013612 (1980-07-01), None
patent: 0669919 (1995-09-01), None
patent: 0885190 (1998-12-01), None
patent: WO 02/48117 (2002-06-01), None
patent: 03/055865 (2003-07-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Somers Maria Victorina Francisca
Van der Aa Marcel Jozef Maria
Van Dun Jacobus Alphonsus Josephus
Van Heertum Albertus Henricus Maria Theresia
Wouters Walter Boudewijin Leopold
Janssen Pharmaceutica NV
Willis Douglas M
Wilson James O
LandOfFree
Substituted 2-alkyl quinazolinone derivatives as PARP... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-alkyl quinazolinone derivatives as PARP..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-alkyl quinazolinone derivatives as PARP... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699354